"liposomal doxorubicin" trang 1 - tải miễn phí từ tailieuXANH
Quantitative determination of phospholipid in liposomal amphotericin B for lyophilized injection by UV-Vis spectrophotometric method

Quantitative determination of phospholipid in liposomal amphotericin B for lyophilized injection by UV-Vis spectrophotometric method
8    154    2
Quantitative determination phospholipid in liposomal amphotericin B for lyophilized injection by UV-Vis spectrophotometric method

Quantitative determination phospholipid in liposomal amphotericin B for lyophilized injection by UV-Vis spectrophotometric method
8    43    0
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer

Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
11    46    0
Ebook Practical chemotherapy - A multidisciplinary guide: Part 1

Ebook Practical chemotherapy - A multidisciplinary guide: Part 1
203    48    0
Ebook Practical chemotherapy - A multidisciplinary guide: Part 2

Ebook Practical chemotherapy - A multidisciplinary guide: Part 2
212    48    0
Methods for particle size reduction of liposomal amphotericin B

Methods for particle size reduction of liposomal amphotericin B
4    49    0
Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations
8    70    0
Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: An open-label, multi-center, non-comparative phase II study

Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: An open-label, multi-center, non-comparative phase II study
8    62    0
The efficacy of liposomal bupivacaine compared with traditional peri-articular injection for pain control following total knee arthroplasty: An updated metaanalysis of randomized controlled trials

The efficacy of liposomal bupivacaine compared with traditional peri-articular injection for pain control following total knee arthroplasty: An updated metaanalysis of randomized controlled trials
12    66    0
Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: Assessment of baseline clinical parameters

Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: Assessment of baseline clinical parameters
10    52    1
Pharmacokinetics and safety of liposomal bupivacaine after local infiltration in healthy Chinese adults: A phase 1 study

Pharmacokinetics and safety of liposomal bupivacaine after local infiltration in healthy Chinese adults: A phase 1 study
7    197    1
Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study
11    36    2
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/ or recurrent osteosarcoma (EuroSarc-Memos trial)

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/ or recurrent osteosarcoma (EuroSarc-Memos trial)
14    124    1
Đánh giá kết quả điều trị ung thư biểu mô buồng trứng tái phát kháng platinum bằng liposomal doxorubicin tại Bệnh viện K giai đoạn 2018 – 2021

Đánh giá kết quả điều trị ung thư biểu mô buồng trứng tái phát kháng platinum bằng liposomal doxorubicin tại Bệnh viện K giai đoạn 2018 – 2021
5    98    1
Đánh giá thời gian sống thêm toàn bộ của bệnh nhân ung thư biểu mô buồng trứng tái phát được hóa trị phác đồ liposomal doxorubicin - carboplatin tại Bệnh viện K

Đánh giá thời gian sống thêm toàn bộ của bệnh nhân ung thư biểu mô buồng trứng tái phát được hóa trị phác đồ liposomal doxorubicin - carboplatin tại Bệnh viện K
5    96    1
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
10    56    0
Báo cáo khoa học:

Báo cáo khoa học: "Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts"
36    49    0
Báo cáo y học:

Báo cáo y học: "Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment"
9    63    0
Báo cáo y học:

Báo cáo y học: "Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis"
15    41    0
Báo cáo y học:

Báo cáo y học: " Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin "
10    49    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.